share_log

Annovis Bio's Cash And Cash Equivalents Totaled $3.1M As Of March 31, 2024, Will Fund Its Operations Into The Fourth Quarter Of 2024

Annovis Bio's Cash And Cash Equivalents Totaled $3.1M As Of March 31, 2024, Will Fund Its Operations Into The Fourth Quarter Of 2024

截至2024年3月31日,Annovis Bio的現金和現金等價物總額爲310萬美元,將爲2024年第四季度的運營提供資金
Benzinga ·  05/13 19:42

Annovis Bio's Cash And Cash Equivalents Totaled $3.1M As Of March 31, 2024, Will Fund Its Operations Into The Fourth Quarter Of 2024

截至2024年3月31日,Annovis Bio的現金和現金等價物總額爲310萬美元,將爲2024年第四季度的運營提供資金

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論